Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
The series begins today, Wednesday, April 24, 2024, and is planned to be held on the last Wednesday of each month.
- The series begins today, Wednesday, April 24, 2024, and is planned to be held on the last Wednesday of each month.
- Each webinar will feature a presentation from a Lantern collaborator, advisor, or researchers followed by a live Q&A.
- These sessions provide a deep dive into the company’s research, collaborations, clinical trials and expected goals for the drug or AI development initiatives.
- Igor Astsaturov, MD is a leading expert in pancreatic cancer collaborating with Lantern Pharma on the LP-184 clinical trial.